Womenz Magazine

Here’s the new drug that could treat depression and suicide

Jonathan Nourok/GettyImages

Researchers published a new study that shows a certain drug could be used to treat depression symptoms that can lead to suicide.

A new study has identified a drug that could have the potential to treat depression and thus cause a massive reduction in suicides.

The drug is called ezogabine and has been shown to be linked to a large reduction in depressive symptoms and anhedonia. Anhedonia is the reduced ability to experience pleasure and is the main symptom of depression as it leads to a poor response to antidepressants and an increased risk of suicide.

Researchers have shown that ezogabine opens up the KCNQ2/3 channel, which is a member of a family of ion channels that act as controllers of brain cell excitability and function.

The researchers gave 45 adult study participants that were diagnosed with a depressive disorder either ezogabine or a placebo. The trial went on for five weeks.

The team found that participants who received ezogabine showed a significant reduction in depression severity, anhedonia, and overall illness severity compared to those participants who received a placebo. Additionally, the researchers stated that the drug basically mimics stress resilience in the brain.

Related posts

The Four life-changing Fitness Tips for those Crossing their 50s

Bente Birkeland

COVID pandemic ’emergency’ alarm sounded, coming ‘disaster’ on horizon

Alex Williams

Bottom blood pressure number may predict your dementia risk

Bente Birkeland